首页>投融资

Heartseed

上市

Heartseed is focusing on the development of pluripotent stem cells for the treatment of cardiac failures.In May 2023, Heartseed raised 2 billion JPY at Series D round.In June 2021, Heartseed Inc announced that it has raised 4 Billion-yen in a Series C round funding that brought its total financial backing to 8.2 Billion yen

http://heartseed.jp/

470225

基本信息

公司全称

Heartseed Inc
类型

心脏再生药物开发商
产业领域

医药研发/制造、化学&生物药
公司人数

15~50人
地址

302, The Artcomplex Center of Tokyo 12-9, Daikyo-cho SHINJUKU-KU TOKYO-TO 160-0015; JP;
联系电话
邮箱

contact@heartseed.jp
成立时间

2015-01-01

投融资

2024-07-30

上市

未透露

未透露
2023-05-25

D轮

20亿日元

Arcus South East Asia

SMBC Venture Capital

Koei Tecmo Capital

Keio Innovation Initiative

Medical Incubator Japan

Japan Co-Invest IV Limited Partnership

Nikon-SBI Innovation Fund

UTokyo IPC
2021-06-11

C轮

3700万美元

SMBC Capital

Itochu Chemical Frontier

MEDIPAL HOLDINGS

Sumitomo Mitsui Trust Investment

Nissay Capital

Keio Innovation Initiative

Medical Incubator Japan

UTokyo IPC

SBI Group
2020-02-29

未透露

未透露

Itochu Chemical Frontier

MEDIPAL HOLDINGS
2019-11-22

B轮

2600万美元

Astellas Venture Management

SMBC Venture Capital

Nissay Capital

Gene Techno

JMDC Japan

SBI Investment
2018-07-30

A轮

8亿日元

Shibuya Corporation

Astellas Venture Management

Angel Bridge
2016-03-14

种子轮

1亿日元

Angel Bridge
加载更多

Heartseed

基本信息

投融资

相关投融资企业